The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients.

[1]  K. Nakagawa,et al.  Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis , 1995, Virchows Archiv.

[2]  K. Takahashi,et al.  Elevated plasma endothelin in patients with diabetes mellitus , 1990, Diabetologia.

[3]  Jerrold M. Olefsky,et al.  Diabetes mellitus : a fundamental and clinical text , 2004 .

[4]  E. Tsilibary.  Microvascular basement membranes in diabetes mellitus , 2003, The Journal of pathology.

[5]  N. de Las Heras,et al.  Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension. , 2002, Kidney international. Supplement.

[6]  A. Baron,et al.  Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. , 2002, Diabetes.

[7]  J. Panza,et al.  Increased Activity of Endogenous Endothelin in Patients With Type II Diabetes Mellitus , 2002, Circulation.

[8]  R. Candido,et al.  Haemodynamics in microvascular complications in type 1 diabetes , 2002, Diabetes/metabolism research and reviews.

[9]  B. Boehm,et al.  Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF). , 2001, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[10]  F. Santilli,et al.  Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria. , 2001, The Journal of clinical endocrinology and metabolism.

[11]  A. Nicolaides,et al.  Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentrations in type 1 diabetic subjects and nondiabetic subjects. , 2001, Metabolism: clinical and experimental.

[12]  M. Shibuya.  Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. , 2001, Cell structure and function.

[13]  D. Cha,et al.  Role of vascular endothelial growth factor in diabetic nephropathy. , 2000, Kidney international. Supplement.

[14]  L. Aiello,et al.  Role of vascular endothelial growth factor in diabetic vascular complications. , 2000, Kidney international. Supplement.

[15]  V. Gopalakrishnan,et al.  Endothelin: emerging role in diabetic vascular complications , 1999, Diabetologia.

[16]  P. Campochiaro,et al.  Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. , 1999, Investigative ophthalmology & visual science.

[17]  Philip D. Harvey,et al.  Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 , 1998, BMJ.

[18]  R. Bucala,et al.  Advanced glycation end products increase retinal vascular endothelial growth factor expression. , 1998, The Journal of clinical investigation.

[19]  L. Lanting,et al.  Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. , 1997, The American journal of physiology.

[20]  K. Ikeda,et al.  The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas , 1997, Diabetologia.

[21]  R. Jain,et al.  Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. , 1997, Science.

[22]  D. Eliott,et al.  Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.

[23]  Joan W. Miller,et al.  Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.

[24]  Joan W. Miller,et al.  Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. , 1996, Archives of ophthalmology.

[25]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[26]  E. Levin.  Mechanisms of disease : endothelins , 1995 .

[27]  T. Masaki.  Possible role of endothelin in endothelial regulation of vascular tone. , 1995, Annual review of pharmacology and toxicology.

[28]  L. Aiello,et al.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.

[29]  Joan W. Miller,et al.  Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. , 1994, American journal of ophthalmology.

[30]  Sakurai Takeshi,et al.  Molecular characterization of endothelin receptors. , 1992 .

[31]  Yanagisawa Masashi,et al.  Molecular biology and biochemistry of the endothelins. , 1989 .

[32]  M. Yanagisawa,et al.  Analysis of endothelin related peptides in culture supernatant of porcine aortic endothelial cells: evidence for biosynthetic pathway of endothelin-1. , 1989, Biochemical and biophysical research communications.

[33]  N. Ferrara,et al.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[34]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.